Genmab — Januar 2025

[E_L]

further translational implementation of our combinatorial concept.

[E_L]

New trial : A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors https://clinicaltrials.gov/study/NCT06771921

[E_L]

Target not disclosed yet. 'estimated trial duration is 8 months for an individual participant /
The treatment duration will be an estimated 3-month treatment period > makes me think this is for a very serious disease? and maybe expect relative toxic drug?

[E_L]

Exclusion Criteria : Prior treatment with aTIGIT, aPD1, aPDL1, aLAG3,
aCTLA-4 ; may give some indication to the target?

[E_L]

Moderna opening -20% on a revenue update, @ $34, i think they traded near $500 at the top...

[E_L]

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology https://www.businesswire.com/news/home/20250113347375/en/AbCellera-Expands-Collaboration-with-AbbVie-to-Develop-Novel-T-Cell-Engagers-for-Oncology?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork

[E_L]

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma https://www.prnewswire.com/news-releases/simcere-zaiming-and-abbvie-announce-partnership-to-develop-a-novel-trispecific-antibody-candidate-in-multiple-myeloma-302349311.html

[E_L]

that Genmab and AbbVie collaboration doesn't seem to be going anywhere besides Epco...

[Sukkeralf]

4,5 years without any information about this part of the deal - so guess they have not done anything at all. Which of them to blame?

[E_L]

my guess is that a 50:50 collaboration is too expensive for a company like Abbvie, unless they get offered an antibody that really knocks it out of the park...

[E_L]

i had hopes for a duohexabody or hexelect, but alas... not expecting much anymore , besides possibly another disease area with Epco

[E_L]

the other side is offcourse also; IF Genmab has a great idea; do they still want to share it... or try to develop it themselves...

[Solsen]

https://www.linkedin.com/posts/janvandewinkel_innovation-antibodyscience-jpm2025-activity-7284646692912562179-Dgdb?utm_source=share&utm_medium=member_ios Winkel

[bikube]

JnJ har udsendt Transcript fra J P Morgans Healthcare Conference, den ligger på Seeking Alfa. Er der ikke noget fra Genmab endnu ?

[E_L]

JNJ have the transcript also on their website https://s203.q4cdn.com/636242992/files/doc_downloads/2024/09/jnj-usq_transcript_2024-09-04.pdf

[E_L]

Genmab will present tonight

[E_L]

sry that was the Morgan Stanley conference for JNJ , JPM not there yet. need stronger coffee...

[E_L]

Xian Deng
UBS Buy Kr.2,700.00 Maintained 13-1-25

[Stroka]

Sikken en sjælden kursfest vi har i aktien lige nu

[ProinvestorNEWS]

Genmab-aktien rummer potentiale på 40 pct. ifølge Handelsbanken https://proinvestor.com/investornyt/1264955/genmab-aktien-rummer-potentiale-pa-40-pct-ifolge-handelsbanken